Deepcell's repository of AI-defined cellular features can be used to improve models for cell characterization and isolation. Further, it can help identify patterns not visible to the human eye. The company plans to use the cell atlas to unlock biological clinical applications that serve as a resource for Deepcell's microfluidic and imaging AI models to profile and enrich target cells.

Stanford University developed Deepcell with the goal of reinventing single-cell analysis through the creation of a quantitative dimension of cell morphology.

Regeneron announces creative innovation 2021 winners
Regeneron announced the winners of its ninth annual Regeneron Prize for Creative Innovation, a competition designed to recognize creativity and independent...

Nuevocor secures $24M for cardiac gene therapies
Nuevocor has completed a $24 million financing round to accelerate the preclinical development of its lead program, an adeno-associated virus-based...

Sanofi, Stanford partner to study immunology
Sanofi has entered into a three-year research collaboration with the Stanford University School of Medicine to advance the understanding of immunology...

Crown Bioscience acquires in vitro services provider OcellO
Crown Bioscience, a JSR Life Sciences company, has acquired OcellO, a privately owned contract research organization in the Netherlands.